SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

urology

Early Signs of Prostate Cancer vs. BPH: What's the Difference

Early prostate cancer usually produces no symptoms — that is why PSA screening exists. Urinary symptoms such as a weak stream or frequent urination are far more often caused by benign prostatic hyperplasia (BPH) than cancer. More concerning signs like bone pain or unexplained weight loss tend to appear in advanced disease and warrant prompt urologist evaluation.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Why early prostate cancer rarely causes symptoms

The prostate gland sits below the bladder, surrounding the urethra. A small cancer in the outer portion of the gland — where most prostate cancers begin — does not compress the urethra and therefore does not cause urinary symptoms in its early stages.

This is a critical point: the absence of urinary symptoms does not mean the prostate is healthy. It also means that by the time symptoms appear, cancer has sometimes grown larger or spread. This is the rationale for PSA screening among men at risk 12.

What symptoms can prostate cancer cause?

When prostate cancer does produce symptoms, they depend on how far the disease has progressed:

Locally advanced disease (cancer growing beyond the prostate capsule or into adjacent structures): - Difficulty starting urination or maintaining a steady stream - Increased frequency, especially at night (nocturia) - Incomplete bladder emptying - Blood in urine (hematuria) or blood in semen - Erectile dysfunction (in some cases)

Metastatic disease (cancer that has spread to lymph nodes, bones, or other organs): - Bone pain, particularly in the lower back, hips, or pelvis — this is one of the more specific warning signs of advanced prostate cancer - Unexplained weight loss - Fatigue - Leg swelling from lymph node involvement

How do prostate cancer symptoms compare to BPH?

Benign prostatic hyperplasia (BPH) — non-cancerous enlargement of the prostate — is extremely common as men age and produces many of the same urinary symptoms: weak stream, frequency, urgency, and incomplete emptying. BPH grows from the inner zone of the prostate (directly around the urethra), so it compresses the urethra and causes symptoms early, even when small 3.

Prostate cancer, by contrast, typically begins in the outer zone, away from the urethra. This is why BPH and prostate cancer can coexist — a man can have bothersome urinary symptoms from BPH and a concurrent prostate cancer that was detectable only by PSA.

Critically, you cannot tell from symptoms alone whether urinary changes are from BPH, cancer, or another cause. A PSA test, rectal exam, and sometimes imaging are needed to distinguish them. If you are experiencing new or worsening urinary symptoms, a urologist can help sort this out 3.

Which symptoms should prompt prompt evaluation?

While most urinary symptoms in men over 50 are ultimately due to BPH or another benign cause, these findings warrant evaluation without delay:

  • Bone pain in the back, hips, or pelvis, especially if new, persistent, or worsening
  • Blood in urine (hematuria) — needs evaluation even if intermittent
  • Blood in semen (hematospermia) — usually benign, but warrants assessment if persistent
  • Unexplained weight loss alongside urinary symptoms
  • Difficulty urinating to the point of retention (unable to urinate at all)

What a urologist looks for in evaluation

A urologist evaluating possible prostate cancer will typically:

1. Review PSA history and trend 2. Perform a digital rectal exam (DRE) to feel for nodules or firmness in the gland 3. Discuss whether imaging (multiparametric MRI) is appropriate before considering biopsy 4. Consider validated symptom scores for BPH (such as the International Prostate Symptom Score) to characterize urinary symptoms

This workup allows the clinician to determine whether a biopsy is warranted and to reassure or treat accordingly 12.

How Gale can help

A Gale primary care clinician can order an initial PSA test, review your symptom history, and help you understand whether a urology referral is appropriate. If your PSA is elevated or your symptoms are concerning, Gale can help coordinate the next step with a urologist.

Common questions

Can prostate cancer cause no symptoms at all?

Yes. Early, localized prostate cancer is often entirely silent. This is why PSA screening was developed — to detect cancer before it produces symptoms.

If I have urinary symptoms, should I assume it is prostate cancer?

No. Urinary symptoms in men over 50 are far more commonly caused by BPH than by cancer. However, symptoms should be evaluated by a clinician, who can perform a PSA test and rectal exam to distinguish likely causes.

Is bone pain a sign of prostate cancer?

Bone pain — particularly in the lower back, hips, or pelvis — can be a sign of prostate cancer that has spread to the bones. It is more characteristic of advanced disease. New, unexplained bone pain in a man warrants medical evaluation.

Can BPH and prostate cancer occur at the same time?

Yes. BPH and prostate cancer are not mutually exclusive. A man can have symptomatic BPH and a separate, concurrent prostate cancer that does not produce its own symptoms. PSA testing is important even if BPH is already known.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Symptoms that warrant prompt medical evaluation

  • New, unexplained bone pain in the back, hips, or pelvis
  • Blood in the urine that is not explained
  • Complete inability to urinate (urinary retention) — this is a medical emergency
  • Rapidly worsening urinary symptoms
  • Unexplained significant weight loss alongside any urinary or pelvic symptoms

Inability to urinate at all (acute urinary retention) requires same-day or emergency care. Go to an emergency department or call your urologist's after-hours line.

Symptoms described here overlap with many benign conditions. This article does not diagnose any condition. See a urologist for a thorough evaluation.

References

  1. 1.Wei JT, Barocas D, Carlsson S, et al. (2023). Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. Journal of Urology. doi:10.1097/JU.0000000000003491Clinical evaluation framework and risk-based screening context
  2. 2.US Preventive Services Task Force (2018). Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. doi:10.1001/jama.2018.3710Background on asymptomatic early prostate cancer and rationale for PSA screening
  3. 3.Lerner LB, McVary KT, Barry MJ, et al. (2021). Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Part I — Initial Work-up and Medical Management. Journal of Urology. doi:10.1097/JU.0000000000002183BPH as the predominant cause of lower urinary tract symptoms and coexistence with prostate cancer

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.